The company Méd-i-vet, created in 2016, specializes in the development and marketing of natural or autologous therapeutic products based on biotechnology innovation.
Our objective is mainly focused on autologous regenerative medicine, the treatment of musculoskeletal, joint, muscular or tendon disorders, the control of moderate to severe bleeding (venous or arterial) in surgery and traumatology, the treatment and healing of wounds and the surgical innovation with the aim of improving the health and quality of life of your patients.
We share this goal with veterinarians, researchers and all our business partners around the world.
PROVIDING EXCELLENT CARE
At the center of all our actions, we make it a point of honor to satisfy and anticipate the needs of our customers and partners. Med-i-vet's first commitment is to support and serve healthcare professionals and all people using its products and solutions. As a leader in our sector, we use all of our resources, human and technological, to design and distribute our products with the greatest efficiency, while respecting the strictest regulatory quality standards.
Méd-i-vet's mission is to offer professionals in the veterinary world the means to provide excellent, natural care using innovative technologies.
Innovation, quality and the choice of natural or autologous solutions are the priority axes of our strategy.
Support, training, digital tools, as well as access to the operating room are essential success factors to improve and optimize the use of our products and support you in the development of your medical and surgical practices.
Serving performance is a leitmotif for all Méd-i-vet employees. The company owes its success to the key skills acquired in innovative medical devices but also to its keen knowledge of the international landscape.
The rapid evolution of biotechnologies and surgical techniques push us to research and distribute innovative technological solutions with the aim of constantly improving clinical effectiveness for the benefit of animal well-being.
At Méd-i-vet we are convinced that veterinary medicine and surgery will quickly evolve towards the use of the same technological developments made in the human health market. This is why we have chosen to devote ourselves to innovation to anticipate the needs of tomorrow, both for the comfort of animals and for the performance of doctors, surgeons and their teams.
Despite the difficulties of the period which particularly shook the world's health sector and in a very complex economic and regulatory context, Méd-i-vet is mobilizing to meet the expectations of professionals in the veterinary world. We work tirelessly to improve the performance and safety of medical devices, taking into account all these parameters and meeting the expectations of our customers and partners. This is our priority.
Méd-i-vet's export distribution policy aims to establish a partnership with distribution companies or laboratories, very well established locally and specialized in the veterinary market. Méd-i-vet has expertise and knowledge of veterinary medical devices and health professionals with whom it collaborates to satisfy its partners, beyond these borders. Our strategy aims to offer an offer structured around innovative and unconventional ranges associated with a fully adapted service. Our sales team is appreciated for its responsiveness and ability to listen.
Serving performance is a leitmotif for all Méd-i-vet employees. The company owes its success to the key skills acquired in innovative medical devices but also to its keen knowledge of the international landscape.